Stabilizes and repairs neuronal cell membranes by stimulating the biosynthesis of structural phospholipids. It also acts as an antioxidant, reduces free radicals, and inhibits apoptosis (cell death).
-Rovalang 500 mg: Each ml contains:
Citicoline Sodium 130.63 mg EquivalenttoanhydrousCiticoline 125mg
Excipients: Sodium hydroxide or Hydrochloric acid q.s. ad pH 6.5 – 7.1, Water for injection.
-Rovalang 1000 mg: Each ml contains:
Citicoline Sodium 261.26 mg EquivalenttoanhydrousCiticoline 250mg
Excipients: Sodium hydroxide or Hydrochloric acid q.s. ad pH 6.5 – 7.1, Water for injection.
• Acute stroke and its neurological sequelae.
• Traumatic brain injury and its neurological sequelae.
Dosage form: Solution for injection.
Adults.
The recommended dose is 500-2000 mg/day, depending on the severity of the symptoms to be treated.
The medicine can be administered by intramuscular injection, slow intravenous injection (from 3 to 5 min, depending on the administered dose) or by intravenous infusion (infusion rate: 40-60 drops per minute).
Elderly.
In this age category, no specific adjustment of the dose of Rovalang is necessary.
Children and adolescents.
The experience of use in children and adolescents is limited; therefore, the medicinal product should only be administered if the expected benefit of therapy exceeds any possible risk
